(Q43847238)

English

Levels of soluble HLA-I and beta2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy.

scientific article published on 11 January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Levels of soluble HLA-I and beta2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

based on heuristic

inferred from title

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

Srdan Verstovsek

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Albitar M

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Johnson M

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Do KA

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Day A

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Jilani I

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Pierce S

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Estey E

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Kantarjian H

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Keating M

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

O'brien S

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Giles FJ

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

11 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

480-488

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404506

0 references

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

21 January 2018

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

21 January 2018

Immunological identity of the small subunit of HL-A antigens and beta2-microglobulin and its turnover on the cell membrane

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum beta2microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic and prognostic factors in acute monocytic leukaemia: an analysis of 51 cases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum beta-2-microglobulin, TNF-alpha and interleukins in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Contribution of β-2 microglobulin levels to the prognostic stratification of survival in patients with myelodysplastic syndrome (MDS)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble HL-A7 Antigen: Localization in the β-Lipoprotein Fraction of Human Serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti HL-A2 Inhibitor in Normal Human Serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble HLA-I in rheumatic diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplant recipient sera derived soluble HLA mediates allele specific CTL apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of soluble form of HLA class I molecule in Japanese patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of immune evasion of human neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of HLA expression during tumour development.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Myelodysplastic syndrome is not merely "preleukemia"

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study of antithymocyte globulin (ATG) in the treatment of patients with 'low-risk' myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Myelodysplastic syndromes standardized response criteria: further definition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Two forms of HLA class I molecules in human plasma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term culture of surface-biotinylated cells: application in non-radioactive analysis of surface protein shedding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Oligoclonal T cell expansion in myelodysplastic syndrome: evidence for an autoimmune process

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased level of serum HLA class I antigens in patients with systemic lupus in patients with systemic lupus erythematosus. Correlation with disease activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404506

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2404506

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215857%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43847238&oldid=2103845965"